跳至主要内容
临床试验/IRCT2016080615666N5
IRCT2016080615666N5已完成3 期

Cardioeffects of deferoxamine in acute and delayed anthracyclins cardiotoxicities

Vice chancellor of research, Shiaz Univeisity of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
2 years 至 18 years(—)
性别
All

入选标准

  • signing informed consent; male or female aged between 2 to 18 years at screening; new pediatric cancer patients who are going to receive Anthracyclin drugs as part of their chemotherapy regimen
  • Exclusion criteria: patients below two years old; patients with previous history of treatment with any kind of chemotherapy or radiotherapy; diagnosis of congenital heart disease, preexisting heart failure and established renal disease

排除标准

  • 未提供

研究者

发起方
Vice chancellor of research, Shiaz Univeisity of Medical Sciences

相似试验